Natural and Synthetic Polymeric Scaffolds


Clinical therapies have increasingly incorporated polymers as the basis for biomaterials. Polymers are natural or synthetic long chain molecules that are formed by linking repetitive monomer units. In the tissue engineering field, polymeric scaffolds have been widely investigated. A scaffold acts as a temporary support matrix for various cell populations in order to achieve tissue repair or regeneration. Clearly, polymer properties and scaffold design greatly impacts the function of incorporated cells as well as the host tissue. Here we discuss several properties, including scaffold fabrication, assembly, structure, biocompatibility, biodegradability and mechanical properties, which must be considered in order to achieve successful tissue regeneration.


Tissue Engineering Hyaluronic Acid Glycolic Acid Tissue Engineering Application Semicrystalline Polymer 


  1. 1.
    Lee KY and Mooney DJ. Hydrogels for tissue engineering. Chem Rev, 2001a, 101(7): 1869–1879.CrossRefGoogle Scholar
  2. 2.
    Vinall RL, Lo SH, and Reddi AH. Regulation of articular chondrocyte phenotype by bone morphogenetic protein 7, interleukin 1, and cellular context is dependent on the cytoskeleton. Exp Cell Res, 2002, 272(1):32–44.CrossRefGoogle Scholar
  3. 3.
    Hung CT, Lima EG, Mauck RL, Taki E, LeRoux MA, Lu HH, et al. Anatomically shaped osteochondral constructs for articular cartilage repair. J Biomech, 2003, 36(12):1853–1864.CrossRefGoogle Scholar
  4. 4.
    Rahfoth B, Weisser J, Sternkopf F, Aigner T, von der Mark K, and Brauer R. Transplantation of allograft chondrocytes embedded in agarose gel into cartilage defects of rabbits. Osteoarthr Cartil, 1998, 6(1):50–65.CrossRefGoogle Scholar
  5. 5.
    Seal BL, Otero TC, and Panitch A. Polymeric biomaterials for tissue and organ regeneration. Mater Sci Eng R Rep, 2001, 34(4–5):147–230.CrossRefGoogle Scholar
  6. 6.
    Dillon GP, Yu X, Sridharan A, Ranieri JP, and Bellamkonda RV. The influence of physical structure and charge on neurite extension in a 3D hydrogel scaffold. J Biomater Sci Polym Ed, 1998, 9(10):1049–1069.CrossRefGoogle Scholar
  7. 7.
    Wang L, Shelton RM, Cooper PR, Lawson M, Triffitt JT, and Barralet JE. Evaluation of sodium alginate for bone marrow cell tissue engineering. Biomaterials, 2003, 24(20): 3475–3481.CrossRefGoogle Scholar
  8. 8.
    Davis TA, Volesky B, and Mucci A. A review of the biochemistry of heavy metal biosorption by brown algae. Water Res, 2003, 37(18):4311–4330.CrossRefGoogle Scholar
  9. 9.
    Rowley JA, Madlambayan G, and Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials, 1999, 20(1):45–53.CrossRefGoogle Scholar
  10. 10.
    Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev, 2002, 54(1): 3–12.CrossRefGoogle Scholar
  11. 11.
    Shapiro L and Cohen S. Novel alginate sponges for cell culture and transplantation. Biomaterials, 1997, 18(8): 583–590.CrossRefGoogle Scholar
  12. 12.
    Guo JF, Jourdian GW, and MacCallum DK. Culture and growth characteristics of chondrocytes encapsulated in alginate beads. Connect Tissue Res, 1989, 19(2–4):277–297.CrossRefGoogle Scholar
  13. 13.
    Pariente JL, Kim BS, and Atala A. In vitro biocompatibility evaluation of naturally derived and synthetic biomaterials using normal human bladder smooth muscle cells. J Urol, 2002, 167(4):1867–1871.CrossRefGoogle Scholar
  14. 14.
    Shimizu T, Yamato M, Kikuchi A, and Okano T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials, 2003, 24(13):2309–2316.CrossRefGoogle Scholar
  15. 15.
    Liu H, Lee YW, and Dean MF. Re-expression of differentiated proteoglycan phenotype by dedifferentiated human chondrocytes during culture in alginate beads. Biochim Biophys Acta, 1998, 1425(3):505–515.Google Scholar
  16. 16.
    Glicklis R, Shapiro L, Agbaria R, Merchuk JC, and Cohen S. Hepatocyte behavior within three-dimensional porous alginate scaffolds. Biotechnol Bioeng, 2000, 67(3):344–353.CrossRefGoogle Scholar
  17. 17.
    Mosahebi A, Simon M, Wiberg M, and Terenghi G. A novel use of alginate hydrogel as Schwann cell matrix. Tissue Eng, 2001, 7(5):525–534.CrossRefGoogle Scholar
  18. 18.
    Leach JB, Bivens KA, Patrick CW, and Schmidt CE. Photocrosslinked hyaluronic acid hydrogels: Natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng, 2003, 82(5):578–589.CrossRefGoogle Scholar
  19. 19.
    Hayashi T. Biodegradable polymers for biomedical uses. Prog Polym Sci, 1994, 19(4): 663–702.CrossRefGoogle Scholar
  20. 20.
    Aigner J, Tegeler J, Hutzler P, Campoccia D, Pavesio A, Hammer C, et al. Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester. J Biomed Mater Res, 1998, 42(2):172–181.CrossRefGoogle Scholar
  21. 21.
    Halbleib M, Skurk T, de Luca C, von Heimburg D, and Hauner H. Tissue engineering of white adipose tissue using hyaluronic acid-based scaffolds. I: in vitro differentiation of human adipocyte precursor cells on scaffolds. Biomaterials, 2003, 24(18):3125–3132.CrossRefGoogle Scholar
  22. 22.
    VandeVord PJ, Matthew HWT, DeSilva SP, Mayton L, Wu B, and Wooley PH. Evaluation of the biocompatibility of a chitosan scaffold in mice. J Biomed Mater Res, 2002, 59(3): 585–590.CrossRefGoogle Scholar
  23. 23.
    Suh JKF and Matthew HWT. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials, 2000, 21(24):2589–2598.CrossRefGoogle Scholar
  24. 24.
    Li J, Pan J, Zhang L, Guo X, and Yu Y. Culture of primary rat hepatocytes within porous chitosan scaffolds. J Biomed Mater Res, 2003, 67A(3):938–943.CrossRefGoogle Scholar
  25. 25.
    Kawase M, Michibayashi N, Nakashima Y, Kurikawa N, Yagi K, and Mizoguchi T. Application of glutaraldehyde-crosslinked chitosan as a scaffold for hepatocyte attachment. Biol Pharm Bull, 1997, 20(6):708–710.Google Scholar
  26. 26.
    Seol YJ, Lee JY, Park YJ, Lee YM, Ku Y, Rhyu IC, et al. Chitosan sponges as tissue engineering scaffolds for bone formation. Biotechnol Lett, 2004, 26(13):1037–1041.CrossRefGoogle Scholar
  27. 27.
    Nettles DL, Elder SH, and Gilbert JA. Potential use of chitosan as a cell scaffold material for cartilage tissue engineering. Tissue Eng, 2002, 8(6):1009–1016.CrossRefGoogle Scholar
  28. 28.
    Lee CH, Singla A, and Lee Y. Biomedical applications of collagen. Int J Pharm, 2001b, 221(1–2):1–22.CrossRefGoogle Scholar
  29. 29.
    Drury JL and Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials, 2003, 24(24):4337–4351.CrossRefGoogle Scholar
  30. 30.
    Ma L, Gao C, Mao Z, Shen J, Hu X, and Han C. Thermal dehydration treatment and glutaraldehyde cross-linking to increase the biostability of collagen-chitosan porous scaffolds used as dermal equivalent. J Biomater Sci Polym Ed, 2003, 14(8):861–874.CrossRefGoogle Scholar
  31. 31.
    Langer R and Vacanti JP. Tissue engineering. Science, 1993, 260(5110):920–926.CrossRefGoogle Scholar
  32. 32.
    Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol, 1998, 134(3): 293–300.CrossRefGoogle Scholar
  33. 33.
    Noah EM, Chen J, Jiao X, Heschel I, and Pallua N. Impact of sterilization on the porous design and cell behavior in collagen sponges prepared for tissue engineering. Biomaterials, 2002, 23(14):2855–2861.CrossRefGoogle Scholar
  34. 34.
    Nehrer S, Breinan HA, Ramappa A, Hsu HP, Minas T, Shortkroff S, et al. Chondrocyte-seeded collagen matrices implanted in a chondral defect in a canine model. Biomaterials, 1998, 19(24):2313–2328.CrossRefGoogle Scholar
  35. 35.
    Risbud MV, Karamuk E, Schlosser V, and Mayer J. Hydrogel-coated textile scaffolds as candidate in liver tissue engineering: II. Evaluation of spheroid formation and viability of hepatocytes. J Biomater Sci-Polym Ed, 2003, 14(7):719–731.CrossRefGoogle Scholar
  36. 36.
    Orwin EJ and Hubel A. In vitro culture characteristics of corneal epithelial, endothelial, and keratocyte cells in a native collagen matrix. Tissue Eng, 2000, 6(4):307–319.CrossRefGoogle Scholar
  37. 37.
    Payne RG, Yaszemski MJ, Yasko AW, and Mikos AG. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 1. Encapsulation of marrow stromal osteoblasts in surface crosslinked gelatin microparticles. Biomaterials, 2002, 23(22):4359–4371.CrossRefGoogle Scholar
  38. 38.
    Awad HA, Wickham MQ, Leddy HA, Gimble JM, and Guilak F. Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials, 2004, 25(16):3211–3222.CrossRefGoogle Scholar
  39. 39.
    Risbud M, Endres M, Ringe J, Bhonde R, and Sittinger M. Biocompatible hydrogel supports the growth of respiratory epithelial cells: possibilities in tracheal tissue engineering. J Biomed Mater Res, 2001, 56(1):120–127.CrossRefGoogle Scholar
  40. 40.
    Altman GH, Diaz F, Jakuba C, Calabro T, Horan RL, Chen J, et al. Silk-based biomaterials. Biomaterials, 2003, 24(3):401–416.CrossRefGoogle Scholar
  41. 41.
    Minoura N, Aiba S, Gotoh Y, Tsukada M, and Imai Y. Attachment and growth of cultured fibroblast cells on silk protein matrices. J Biomed Mater Res, 1995, 29(10):1215–1221.CrossRefGoogle Scholar
  42. 42.
    Sofia S, McCarthy MB, Gronowicz G, and Kaplan DL. Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res, 2001, 54(1):139–148.CrossRefGoogle Scholar
  43. 43.
    Middleton JC and Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials, 2000, 21(23):2335–2346.CrossRefGoogle Scholar
  44. 44.
    Thomson RC, Wake MC, Yaszemski MJ, and Mikos AG. Biodegradable polymer scaffolds to regenerate organs. Biopolymers II, 1995,122:245–274.Google Scholar
  45. 45.
    Gunatillake PA and Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater, 2003,5:1–16; discussion 16.Google Scholar
  46. 46.
    Yang S, Leong KF, Du Z, and Chua CK. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng, 2001, 7(6):679–689.CrossRefGoogle Scholar
  47. 47.
    Freed LE, Marquis JC, Nohria A, Emmanual J, Mikos AG, and Langer R. Neocartilage formation invitro and invivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res, 1993, 27(1):11–23.CrossRefGoogle Scholar
  48. 48.
    Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, et al. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation, 1996, 94(9) Suppl II:164–168.Google Scholar
  49. 49.
    Kaihara S, Kim S, Kim BS, Mooney DJ, Tanaka K, and Vacanti JP. Survival and function of rat hepatocytes cocultured with nonparenchymal cells or sinusoidal endothelial cells on biodegradable polymers under flow conditions. J Pediatr Surg, 2000, 35(9):1287–1290.CrossRefGoogle Scholar
  50. 50.
    Mooney DJ, Mazzoni CL, Breuer C, McNamara K, Hern D, Vacanti JP, et al. Stabilized polyglycolic acid fibre-based tubes for tissue engineering. Biomaterials, 1996a, 17(2): 115–124.CrossRefGoogle Scholar
  51. 51.
    Agrawal CM and Ray RB. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomed Mater Res, 2001, 55(2):141–150.CrossRefGoogle Scholar
  52. 52.
    Ishaug-Riley SL, Okun LE, Prado G, Applegate MA, and Ratcliffe A. Human articular chondrocyte adhesion and proliferation on synthetic biodegradable polymer films. Biomaterials, 1999, 20(23–24):2245–56.CrossRefGoogle Scholar
  53. 53.
    Park SS, Jin HR, Chi DH, and Taylor RS. Characteristics of tissue-engineered cartilage from human auricular chondrocytes. Biomaterials, 2004, 25(12):2363–2369.CrossRefGoogle Scholar
  54. 54.
    Yang F, Murugan R, Ramakrishna S, Wang X, Ma YX, and Wang S. Fabrication of nano-structured porous PLLA scaffold intended for nerve tissue engineering. Biomaterials, 2004, 25(10):1891–1900.CrossRefGoogle Scholar
  55. 55.
    El-Amin SF, Lu HH, Khan Y, Burems J, Mitchell J, Tuan RS, et al. Extracellular matrix production by human osteoblasts cultured on biodegradable polymers applicable for tissue engineering. Biomaterials, 2003, 24(7):1213–1221.CrossRefGoogle Scholar
  56. 56.
    Mooney DJ, Organ G, Vacanti JP, and Langer R. Design and fabrication of biodegradable polymer devices to engineer tubular tissues. Cell Transplant, 1994, 3(2):203–210.Google Scholar
  57. 57.
    Kim BS, Nikolovski J, Bonadio J, Smiley E, and Mooney DJ. Engineered smooth muscle tissues: regulating cell phenotype with the scaffold. Exp Cell Res, 1999, 251(2): 318–328.CrossRefGoogle Scholar
  58. 58.
    Teng YD, Lavik EB, Qu X, Park KI, Ourednik J, Zurakowski D, et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A, 2002, 99(5):3024–3029.CrossRefGoogle Scholar
  59. 59.
    Dai NT, Williamson MR, Khammo N, Adams EF, and Coombes AG. Composite cell support membranes based on collagen and polycaprolactone for tissue engineering of skin. Biomaterials, 2004, 25(18):4263–4271.CrossRefGoogle Scholar
  60. 60.
    Barralet JE, Wallace LL, and Strain AJ. Tissue engineering of human biliary epithelial cells on polyglycolic acid/polycaprolactone scaffolds maintains long-term phenotypic stability. Tissue Eng, 2003, 9(5):1037–1045.CrossRefGoogle Scholar
  61. 61.
    Park YJ, Lee JY, Chang YS, Jeong JM, Chung JK, Lee MC, et al. Radioisotope carrying polyethylene oxide-polycaprolactone copolymer micelles for targetable bone imaging. Biomaterials, 2002, 23(3):873–879.CrossRefGoogle Scholar
  62. 62.
    Ciapetti G, Ambrosio L, Savarino L, Granchi D, Cenni E, Baldini N, et al. Osteoblast growth and function in porous poly epsilon-caprolactone matrices for bone repair: a preliminary study. Biomaterials, 2003, 24(21):3815–3824.CrossRefGoogle Scholar
  63. 63.
    Ng KW, Hutmacher DW, Schantz JT, Ng CS, Too HP, Lim TC, et al. Evaluation of ultra-thin poly(epsilon-caprolactone) films for tissue-engineered skin. Tissue Eng, 2001, 7(4): 441–455.CrossRefGoogle Scholar
  64. 64.
    Fisher JP, Vehof JW, Dean D, van der Waerden JP, Holland TA, Mikos AG, et al. Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model. J Biomed Mater Res, 2002, 59(3):547–56.CrossRefGoogle Scholar
  65. 65.
    Fisher JP, Holland TA, Dean D, and Mikos AG. Photoinitiated cross-linking of the biodegradable polyester poly(propylene fumarate). Part II. In vitro degradation. Biomacromolecules, 2003, 4(5):1335–1342.CrossRefGoogle Scholar
  66. 66.
    Peter SJ, Miller MJ, Yasko AW, Yaszemski MJ, and Mikos AG. Polymer concepts in tissue engineering. J Biomed Mater Res, 1998, 43(4):422–427.CrossRefGoogle Scholar
  67. 67.
    Suggs LJ and Mikos AG. Development of poly(propylene fumarate-co-ethylene glycol) as an injectable carrier for endothelial cells. Cell Transplant, 1999, 8(4):345–350.Google Scholar
  68. 68.
    Shung AK, Behravesh E, Jo S, and Mikos AG. Crosslinking characteristics of and cell adhesion to an injectable poly(propylene fumarate-co-ethylene glycol) hydrogel using a water-soluble crosslinking system. Tissue Eng, 2003, 9(2):243–254.CrossRefGoogle Scholar
  69. 69.
    Davis KA and Anseth KS. Controlled release from crosslinked degradable networks. Crit Rev Ther Drug Carrier Syst, 2002, 19(4–5):385–423.CrossRefGoogle Scholar
  70. 70.
    Heller J, Barr J, Ng SY, Abdellauoi KS, and Gurny R. Poly(ortho esters): Synthesis, characterization, properties and uses. Adv Drug Deliv Rev, 2002, 54(7):1039–1039.CrossRefGoogle Scholar
  71. 71.
    Andriano KP, Tabata Y, Ikada Y, Heller J. In vitro and in vivo comparison of bulk and surface hydrolysis in absorbable polymer scaffolds for tissue engineering. J Biomed Mater Res, 1999, 48(5):602–612.CrossRefGoogle Scholar
  72. 72.
    Vacanti JP, Morse MA, Saltzman WM, Domb AJ, Perez-Atayde A, and Langer R. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg, 1988, 23(1 Pt 2):3–9.CrossRefGoogle Scholar
  73. 73.
    Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc Chem Res, 2000, 33(2):94–101.CrossRefGoogle Scholar
  74. 74.
    Kumar N, Langer RS, and Domb AJ. Polyanhydrides: an overview. Adv Drug Deliv Rev, 2002, 54(7):889–910.CrossRefGoogle Scholar
  75. 75.
    Burkoth AK, Burdick J, and Anseth KS. Surface and bulk modifications to photocrosslinked polyanhydrides to control degradation behavior. J Biomed Mater Res, 2000a, 51(3): 352–359.CrossRefGoogle Scholar
  76. 76.
    Burkoth AK and Anseth KS. A review of photocrosslinked polyanhydrides: in situ forming degradable networks. Biomaterials, 2000b, 21(23):2395–2404.CrossRefGoogle Scholar
  77. 77.
    Uhrich KE, Gupta A, Thomas TT, Laurencin CT, and Langer R. Synthesis and characterization of degradable poly(anhydride-co-imides). Macromolecules, 1995, 28(7): 2184–2193.CrossRefGoogle Scholar
  78. 78.
    Muggli DS, Burkoth AK, and Anseth KS. Crosslinked polyanhydrides for use in orthopedic applications: degradation behavior and mechanics. J Biomed Mater Res, 1999, 46(2): 271–278.CrossRefGoogle Scholar
  79. 79.
    Qiu LY and Zhu KJ. Novel biodegradable polyphosphazenes containing glycine ethyl ester and benzyl ester of amino acethydroxamic acid as cosubstituents: syntheses, characterization, and degradation properties. J Appl Polym Sci, 2000, 77(13):2987–2995.CrossRefGoogle Scholar
  80. 80.
    Laurencin CT, Norman ME, Elgendy HM, el-Amin SF, Allcock HR, Pucher SR, et al. Use of polyphosphazenes for skeletal tissue regeneration. J Biomed Mater Res, 1993, 27(7): 963–973.CrossRefGoogle Scholar
  81. 81.
    Laurencin CT, El-Amin SF, Ibim SE, Willoughby DA, Attawia M, Allcock HR, et al. A highly porous 3-dimensional polyphosphazene polymer matrix for skeletal tissue regeneration. J Biomed Mater Res, 1996, 30(2):133–138.CrossRefGoogle Scholar
  82. 82.
    Langone F, Lora S, Veronese FM, Caliceti P, Parnigotto PP, Valenti F, et al. Peripheral nerve repair using a poly(organo)phosphazene tubular prosthesis. Biomaterials, 1995, 16(5): 347–353.CrossRefGoogle Scholar
  83. 83.
    Tangpasuthadol V, Pendharkar SM, and Kohn J. Hydrolytic degradation of tyrosine-derived polycarbonates, a class of new biomaterials. Part I: Study of model compounds. Biomaterials, 2000, 21(23):2371–2378.CrossRefGoogle Scholar
  84. 84.
    Choueka J, Charvet JL, Koval KJ, Alexander H, James KS, Hooper KA, et al. Canine bone response to tyrosine-derived polycarbonates and poly(L-lactic acid). J Biomed Mater Res, 1996, 31(1):35–41.CrossRefGoogle Scholar
  85. 85.
    Lee SJ, Choi JS, Park KS, Khang G, Lee YM, and Lee HB. Response of MG63 osteoblast-like cells onto polycarbonate membrane surfaces with different micropore sizes. Biomaterials, 2004a, 25(19):4699–4707.CrossRefGoogle Scholar
  86. 86.
    Cai J, Bo S, Cheng R, Jiang L, and Yang Y. Analysis of interfacial phenomena of aqueous solutions of polyethylene oxide and polyethylene glycol flowing in hydrophilic and hydrophobic capillary viscometers. J Colloid Interface Sci, 2004, 276(1):174–181.CrossRefGoogle Scholar
  87. 87.
    Gutowska A, Jeong B, Jasionowski M. Injectable gels for tissue engineering. Anat Rec, 2001, 263(4):342–349.CrossRefGoogle Scholar
  88. 88.
    Bourke SL and Kohn J. Polymers derived from the amino acid L-tyrosine: polycarbonates, polyarylates and copolymers with poly(ethylene glycol). Adv Drug Deliv Rev, 2003;55(4):447–466.CrossRefGoogle Scholar
  89. 89.
    Novikova LN, Novikov LN, and Kellerth JO. Biopolymers and biodegradable smart implants for tissue regeneration after spinal cord injury. Curr Opin Neurol, 2003, 16(6):711–715.CrossRefGoogle Scholar
  90. 90.
    Sawhney AS, Pathak CP, and Hubbell JA. Bioerodible hydrogels nased on photopolymerized poly(ethylene glycol)-co-poly(alpha-hydroxy acid) diacrylate macromers. Macromolecules, 1993, 26(4):581–587.CrossRefGoogle Scholar
  91. 91.
    Sims CD, Butler PE, Casanova R, Lee BT, Randolph MA, Lee WP, et al. Injectable cartilage using polyethylene oxide polymer substrates. Plast Reconstr Surg, 1996, 98(5): 843–850.CrossRefGoogle Scholar
  92. 92.
    Bryant SJ and Anseth KS. Controlling the spatial distribution of ECM components in degradable PEG hydrogels for tissue engineering cartilage. J Biomed Mater Res, 2003, 64A(1): 70–79.CrossRefGoogle Scholar
  93. 93.
    Desai NP, Sojomihardjo A, Yao Z, Ron N, and Soon-Shiong P. Interpenetrating polymer networks of alginate and polyethylene glycol for encapsulation of islets of Langerhans. J Microencapsul, 2000, 17(6):677–690.CrossRefGoogle Scholar
  94. 94.
    Ganta SR, Piesco NP, Long P, Gassner R, Motta LF, Papworth GD, et al. Vascularization and tissue infiltration of a biodegradable polyurethane matrix. J Biomed Mater Res, 2003, 64A(2):242–248.CrossRefGoogle Scholar
  95. 95.
    Gorna K and Gogolewski S. Preparation, degradation, and calcification of biodegradable polyurethane foams for bone graft substitutes. J Biomed Mater Res, 2003, 67A(3): 813–827.CrossRefGoogle Scholar
  96. 96.
    Zhang J, Doll BA, Beckman EJ, and Hollinger JO. A biodegradable polyurethane-ascorbic acid scaffold for bone tissue engineering. J Biomed Mater Res, 2003, 67A(2):389–400.CrossRefGoogle Scholar
  97. 97.
    Grad S, Kupcsik L, Gorna K, Gogolewski S, and Alini M. The use of biodegradable polyurethane scaffolds for cartilage tissue engineering: potential and limitations. Biomaterials, 2003, 24(28):5163–5171.CrossRefGoogle Scholar
  98. 98.
    McDevitt TC, Woodhouse KA, Hauschka SD, Murry CE, and Stayton PS. Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. J Biomed Mater Res, 2003, 66A(3):586–595.CrossRefGoogle Scholar
  99. 99.
    Sachlos E and Czernuszka JT. Making tissue engineering scaffolds work. Review: The application of solid freeform fabrication technology to the production of tissue engineering scaffolds. Eur Cell Mater, 2003,5:29–39; discussion 39–40.Google Scholar
  100. 100.
    Mikos AG, Bao Y, Cima LG, Ingber DE, Vacanti JP, and Langer R. Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res, 1993, 27(2):183–189.CrossRefGoogle Scholar
  101. 101.
    Mikos AG, Thorsen AJ, Czerwonka LA, Bao Y, Langer R, Winslow DN, et al. Preparation and characterization of poly(L-lactic acid) foams. Polymer, 1994, 35(5):1068–1077.CrossRefGoogle Scholar
  102. 102.
    Hua FJ, Kim GE, Lee JD, Son YK, and Lee DS. Macroporous poly(L-lactide) scaffold 1. Preparation of a macroporous scaffold by liquid – liquid phase separation of a PLLA – dioxane – water system. J Biomed Mater Res, 2002, 63(2):161–167.CrossRefGoogle Scholar
  103. 103.
    Ma PX and Zhang R. Synthetic nano-scale fibrous extracellular matrix. J Biomed Mater Res, 1999, 46(1):60–72.CrossRefGoogle Scholar
  104. 104.
    Nam YS and Park TG. Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation. J Biomed Mater Res, 1999, 47(1):8–17.CrossRefGoogle Scholar
  105. 105.
    Hsu YY, Gresser JD, Trantolo DJ, Lyons CM, Gangadharam PR, and Wise DL. Effect of polymer foam morphology and density on kinetics of in vitro controlled release of isoniazid from compressed foam matrices. J Biomed Mater Res, 1997, 35(1):107–116.CrossRefGoogle Scholar
  106. 106.
    Whang K, Tsai DC, Nam EK, Aitken M, Sprague SM, Patel PK, et al. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. J Biomed Mater Res, 1998, 42(4):491–499.CrossRefGoogle Scholar
  107. 107.
    Chen GP, Ushida T, and Tateishi T. Development of biodegradable porous scaffolds for tissue engineering. Mater Sci Eng C-Biomimetic Supramol Syst 2001;17(1–2):63–69.CrossRefGoogle Scholar
  108. 108.
    Nam YS, Yoon JJ, and Park TG. A novel fabrication method of macroporous biodegradable polymer scaffolds using gas foaming salt as a porogen additive. J Biomed Mater Res, 2000, 53(1):1–7.CrossRefGoogle Scholar
  109. 109.
    Mooney DJ, Baldwin DF, Suh NP, Vacanti JP, and Langer R. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials, 1996b, 17(14):1417–1422.CrossRefGoogle Scholar
  110. 110.
    Sheridan MH, Shea LD, Peters MC, and Mooney DJ. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release, 2000, 64(1–3):91–102.CrossRefGoogle Scholar
  111. 111.
    Yang S, Leong KF, Du Z, and Chua CK. The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping techniques. Tissue Eng, 2002, 8(1):1–11.CrossRefGoogle Scholar
  112. 112.
    Hutmacher DW. Scaffold design and fabrication technologies for engineering tissues – state of the art and future perspectives. J Biomater Sci Polym Ed, 2001, 12(1):107–124.CrossRefGoogle Scholar
  113. 113.
    Zein I, Hutmacher DW, Tan KC, and Teoh SH. Fused deposition modeling of novel scaffold architectures for tissue engineering applications. Biomaterials, 2002, 23(4): 1169–1185.CrossRefGoogle Scholar
  114. 114.
    Zeltinger J, Landeen LK, Alexander HG, Kidd ID, and Sibanda B. Development and characterization of tissue-engineered aortic valves. Tissue Eng, 2001, 7(1):9–22.CrossRefGoogle Scholar
  115. 115.
    Cima LG, Vacanti JP, Vacanti C, Ingber D, Mooney D, and Langer R. Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng, 1991, 113(2): 143–151.CrossRefGoogle Scholar
  116. 116.
    Cooke MN, Fisher JP, Dean D, Rimnac C, Mikos AG. Use of stereolithography to manufacture critical-sized 3D biodegradable scaffolds for bone ingrowth. J Biomed Mater Res, 2003, 64B(2):65–69.CrossRefGoogle Scholar
  117. 117.
    Lu Y and Chen SC. Micro and nano-fabrication of biodegradable polymers for drug delivery. Adv Drug Deliv Rev, 2004, 56(11):1621–1633.CrossRefGoogle Scholar
  118. 118.
    Angelova N and Hunkeler D. Rationalizing the design of polymeric biomaterials. Trends Biotechnol, 1999, 17(10):409–421.CrossRefGoogle Scholar
  119. 119.
    Ma PX and Choi JW. Biodegradable polymer scaffolds with well-defined interconnected spherical pore network. Tissue Eng, 2001, 7(1):23–33.CrossRefGoogle Scholar
  120. 120.
    Lee SH, Kim BS, Kim SH, Kang SW, and Kim YH. Thermally produced biodegradable scaffolds for cartilage tissue engineering. Macromol Biosci, 2004b, 4(8):802–810.CrossRefGoogle Scholar
  121. 121.
    Lu L and Mikos AG. The importance of new processing techniques in tissue engineering. MRS Bull, 1996, 21(11):28–32.Google Scholar
  122. 122.
    Shin H, Jo S, and Mikos AG. Biomimetic materials for tissue engineering. Biomaterials, 2003, 24(24):4353–4364.CrossRefGoogle Scholar
  123. 123.
    Holy CE, Fialkov JA, Davies JE, and Shoichet MS. Use of a biomimetic strategy to engineer bone. J Biomed Mater Res A, 2003, 65A(4):447–453.CrossRefGoogle Scholar
  124. 124.
    Cunliffe D, Pennadam S, and Alexander C. Synthetic and biological polymers-merging the interface. Eur Polym J, 2004, 40(1):5–25.CrossRefGoogle Scholar
  125. 125.
    Shive MS and Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 1997, 28(1):5–24.CrossRefGoogle Scholar
  126. 126.
    Ziats NP, Miller KM, and Anderson JM. In vitro and in vivo interactions of cells with biomaterials. Biomaterials, 1988, 9(1):5–13.CrossRefGoogle Scholar
  127. 127.
    Anderson JM and Miller KM. Biomaterial biocompatibility and the macrophage. Biomaterials, 1984, 5(1):5–10.CrossRefGoogle Scholar
  128. 128.
    von Burkersroda F, Schedl L, and Gopferich A. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials, 2002, 23(21):4221–4231.CrossRefGoogle Scholar
  129. 129.
    Temenoff JS, Athanasiou KA, LeBaron RG, and Mikos AG. Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. J Biomed Mater Res, 2002, 59(3):429–437.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag US 2009

Authors and Affiliations

  1. 1.Department of Chemical EngineeringUniversity of MarylandCollege ParkUSA
  2. 2.Fischell Department of BioengineeringUniversity of MarylandCollege ParkUSA

Personalised recommendations